Leaflet ALOFISEL 5 MILLIONS OF CELLS/ml 30millions of cells / 6ml injection suspension

Product code:
Y002
Quantity:
4
Indicated for:
complex perianal fistulas in Crohn's disease
Route of administration:
injectable
Substance:
darvadstrocel (cell therapy)
ATC
L04AX08 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants
Darvadstrocel is a cell therapy product used for the treatment of complex perianal fistulas in patients with Crohn's disease. It contains mesenchymal stem cells derived from adipose tissue, which have anti-inflammatory and regenerative properties.

The medication is administered via direct injection into the affected tissues, and the procedure is performed by a specialist. Common side effects include pain at the injection site, fever, and local inflammatory reactions.

Darvadstrocel is contraindicated in patients with active infections or hypersensitivity to any of the product's components. Its use also requires careful monitoring to prevent complications.

This medication is an innovative option for patients with complex perianal fistulas, helping to reduce inflammation and promote tissue healing.

General data about ALOFISEL 5 MILLIONS OF CELLS/ml 30millions of cells / 6ml

Substance:
darvadstrocel
Date of latest medicines list:
01-06-2020
Product code:
Y002
Concentration:
30millions of cells / 6ml
Pharmaceutical form:
injection suspension
Quantity:
4
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for darvadstrocel

Concentrations available for darvadstrocel

  • 30millions of cells/6ml
  • 5 x 10{6} celule/ml